{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:13Z","timestamp":1781636053561,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypophosphatemia during pregnancy poses unique clinical challenges due to physiological changes in mineral metabolism, with potential impacts on maternal and fetal health, but limited evidence to guide treatment. We describe the case of a woman with X-linked hypophosphatemia, previously treated with burosumab for lower limb pseudofractures. Due to her desire for pregnancy and the absence of safety data on burosumab during gestation, the drug was discontinued and treatment with phosphate supplements and calcitriol was initiated. Following assisted reproduction with preimplantation genetic diagnosis, the patient successfully carried the pregnancy to term and delivered a healthy newborn. Monthly biochemical monitoring allowed for safe adjustment of therapy, maintaining serum phosphate levels within or near the normal range without maternal or fetal complications. We also review the available literature on hypophosphatemia in pregnancy, emphasizing the need for individualized management and close monitoring.<\/jats:p>","DOI":"10.1007\/s00223-026-01495-w","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:51:53Z","timestamp":1770893513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of X-Linked Hypophosphatemia During Pregnancy: Case Report and Literature Review"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-4449","authenticated-orcid":false,"given":"Gaetano Paride","family":"Arcidiacono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9413-3710","authenticated-orcid":false,"given":"Mor Peleg","family":"Falb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1426-1452","authenticated-orcid":false,"given":"Marco Onofrio","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-951X","authenticated-orcid":false,"given":"Valentina","family":"Camozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Diogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Guidolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberta","family":"Cecchinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0377-3741","authenticated-orcid":false,"given":"Elena","family":"Campello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-383X","authenticated-orcid":false,"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-9749","authenticated-orcid":false,"given":"Sandro","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8645-4067","authenticated-orcid":false,"given":"Stefania","family":"Sella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1495_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s2213-8587(19)30426-7","volume":"8","author":"P Florenzano","year":"2020","unstructured":"Florenzano P, Cipriani C, Roszko KL et al (2020) Approach to patients with hypophosphataemia. Lancet Diabetes Endocrinol 8:163\u2013174. https:\/\/doi.org\/10.1016\/s2213-8587(19)30426-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1495_CR2","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/jme-20-0089","volume":"66","author":"S Fukumoto","year":"2021","unstructured":"Fukumoto S (2021) FGF23-related hypophosphatemic rickets\/osteomalacia: diagnosis and new treatment. J Mol Endocrinol 66:R57\u2013R65. https:\/\/doi.org\/10.1530\/jme-20-0089","journal-title":"J Mol Endocrinol"},{"key":"1495_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM et al (2019) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 15:435\u2013455. https:\/\/doi.org\/10.1038\/s41581-019-0152-5","journal-title":"Nat Rev Nephrol"},{"key":"1495_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"Insogna KL, Briot K, Imel EA et al (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33:1383\u20131393. https:\/\/doi.org\/10.1002\/jbmr.3475","journal-title":"J Bone Miner Res"},{"key":"1495_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02611-7","author":"G Baroncelli","year":"2025","unstructured":"Baroncelli G, Marco B, Luisa BM et al (2025) Experts\u2019 consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-025-02611-7","journal-title":"J Endocrinol Invest"},{"key":"1495_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02596-3","author":"GP Arcidiacono","year":"2025","unstructured":"Arcidiacono GP, Camozzi V, Tripepi G et al (2025) Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-025-02596-3","journal-title":"J Endocrinol Invest"},{"key":"1495_CR7","doi-asserted-by":"publisher","first-page":"e2347","DOI":"10.1210\/clinem\/dgaf180","volume":"110","author":"DS Ali","year":"2025","unstructured":"Ali DS, Alsarraf F, Alrob HA et al (2025) Current practices in monitoring children and adults with X-linked hypophosphatemia: a global survey of expert experience. J Clin Endocrinol Metab 110:e2347\u2013e2361. https:\/\/doi.org\/10.1210\/clinem\/dgaf180","journal-title":"J Clin Endocrinol Metab"},{"key":"1495_CR8","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1515\/cclm-2023-1292","volume":"62","author":"GP Arcidiacono","year":"2024","unstructured":"Arcidiacono GP, Camozzi V, Zaninotto M et al (2024) Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes. Clin Chem Lab Med (CCLM) 62:1126\u20131132. https:\/\/doi.org\/10.1515\/cclm-2023-1292","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"1495_CR9","unstructured":"Kovacs CS (2000) Calcium and Phosphate Metabolism and Related Disorders During Pregnancy and Lactation. In: Feingold KR, Ahmed SF, Anawalt B, et al (eds) Endotext. MDText.com, Inc., South Dartmouth (MA)"},{"key":"1495_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/physrev.00027.2015","volume":"96","author":"CS Kovacs","year":"2016","unstructured":"Kovacs CS (2016) Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery. Physiol Rev 96:449\u2013547. https:\/\/doi.org\/10.1152\/physrev.00027.2015","journal-title":"Physiol Rev"},{"key":"1495_CR11","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/jbmr.1925","volume":"28","author":"BJ Kirby","year":"2013","unstructured":"Kirby BJ, Ma Y, Martin HM et al (2013) Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone. J Bone Miner Res 28:1987\u20132000. https:\/\/doi.org\/10.1002\/jbmr.1925","journal-title":"J Bone Miner Res"},{"key":"1495_CR12","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1210\/en.2013-2061","volume":"155","author":"Y Ma","year":"2014","unstructured":"Ma Y, Samaraweera M, Cooke-Hubley S et al (2014) Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization. Endocrinology 155:1596\u20131605. https:\/\/doi.org\/10.1210\/en.2013-2061","journal-title":"Endocrinology"},{"key":"1495_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101844","volume":"38","author":"KE Cherian","year":"2024","unstructured":"Cherian KE, Paul TV (2024) Inherited fibroblast growth factor 23 excess. Best Pract Res Clin Endocrinol Metab 38:101844. https:\/\/doi.org\/10.1016\/j.beem.2023.101844","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1495_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.12891\/ceog4385.2018","volume":"45","author":"A Dobrowolska-Redo","year":"2018","unstructured":"Dobrowolska-Redo A, Teliga-Czajkowska J, Sotowska A et al (2018) Pregnancy in patient with X-linked hypophosphatemic rickets \u2013 management and outcome. Clin Exp Obstet Gynecol 45:794\u2013796. https:\/\/doi.org\/10.12891\/ceog4385.2018","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1495_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad114.427","volume":"7","author":"DS Ali","year":"2023","unstructured":"Ali DS, Khan AA (2023) THU466 XLH during pregnancy: a closer look based on real-world experience. J Endocr Soc 7:bvad114.427. https:\/\/doi.org\/10.1210\/jendso\/bvad114.427","journal-title":"J Endocr Soc"},{"key":"1495_CR16","doi-asserted-by":"publisher","DOI":"10.60787\/NMJ.V65I6.603","author":"PM Dogra","year":"2025","unstructured":"Dogra PM, Bhavna B, Kaundal A et al (2025) Hypophosphatemia in pregnancy: a case report. Niger Med J. https:\/\/doi.org\/10.60787\/NMJ.V65I6.603","journal-title":"Niger Med J"},{"key":"1495_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omae125","author":"TBN Truong","year":"2024","unstructured":"Truong TBN, Nguyen AT, Ly LD (2024) Full-term pregnancy despite severe hypophosphatemia caused by tumor-induced osteomalacia. Oxf Med Case Rep. https:\/\/doi.org\/10.1093\/omcr\/omae125","journal-title":"Oxf Med Case Rep"},{"key":"1495_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-02916-0","author":"CR Muniz","year":"2021","unstructured":"Muniz CR, Bezerra GAM, Da Silva VC et al (2021) Ethmoid glomangioma and oncogenic osteomalacia: a case report. J Med Case Rep. https:\/\/doi.org\/10.1186\/s13256-021-02916-0","journal-title":"J Med Case Rep"},{"key":"1495_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.aace.2021.06.008","volume":"7","author":"M Sum","year":"2021","unstructured":"Sum M, Hoda ST, Rapp T, Zan E (2021) Tumor-induced osteomalacia localized and excised after pregnancy. AACE Clin Case Rep 7:363\u2013366. https:\/\/doi.org\/10.1016\/j.aace.2021.06.008","journal-title":"AACE Clin Case Rep"},{"key":"1495_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101819","volume":"24","author":"C Jarvis","year":"2025","unstructured":"Jarvis C, Ramakrishnan R, Dharmaraj P et al (2025) Impact of stopping burosumab treatment at the end of skeletal growth in adolescents with X-linked hypophosphatemia (XLH). Bone Rep 24:101819. https:\/\/doi.org\/10.1016\/j.bonr.2024.101819","journal-title":"Bone Rep"},{"key":"1495_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/gco.0000000000000641","volume":"32","author":"FR P\u00e9rez-L\u00f3pez","year":"2020","unstructured":"P\u00e9rez-L\u00f3pez FR, Pilz S, Chedraui P (2020) Vitamin D supplementation during pregnancy: an overview. Curr Opin Obstet Gynecol 32:316\u2013321. https:\/\/doi.org\/10.1097\/gco.0000000000000641","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1495_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","volume":"41","author":"D Chesher","year":"2018","unstructured":"Chesher D, Oddy M, Darbar U et al (2018) Outcome of adult patients with X\u2010linked hypophosphatemia caused by PHEX gene mutations. J Inherit Metab Dis 41:865\u2013876. https:\/\/doi.org\/10.1007\/s10545-018-0147-6","journal-title":"J Inherit Metab Dis"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01495-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01495-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01495-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:09:46Z","timestamp":1781633386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01495-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1495"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01495-w","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The patient has provided informed consent for the submission of the case report to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Rights"}}],"article-number":"31"}}